PRMT1 and ovarian carcinoma: In comparison to tumors derived from ovarian cancer A2780 cells, those cells with stable knockdown of PRMT1 using the shRNA approach exhibited sharply decreased tumor growth as well as reduced tumor weight (Figs. 2a–c, S2a), implying that depletion of PRMT1 attenuated ovarian tumor growth.